ALPS Advisors’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,569
Closed -$330K 1014
2023
Q2
$330K Buy
1,569
+10
+0.6% +$1.99K ﹤0.01% 791
2023
Q1
$315K Buy
1,559
+84
+6% +$19K ﹤0.01% 827
2022
Q4
$321K Sell
1,475
-9
-0.6% -$1.97K ﹤0.01% 818
2022
Q3
$292K Buy
+1,484
New +$320K ﹤0.01% 842
2022
Q1
Sell
-851
Closed -$321K 862
2021
Q4
$321K Buy
851
+18
+2% +$6.99K ﹤0.01% 817
2021
Q3
$344K Sell
833
-341
-29% -$142K ﹤0.01% 765
2021
Q2
$434K Hold
1,174
﹤0.01% 546
2021
Q1
$340K Buy
1,174
+11
+0.9% +$3.06K ﹤0.01% 646
2020
Q4
$291K Sell
1,163
-35
-3% -$8.34K ﹤0.01% 733
2020
Q3
$271K Sell
1,198
-573
-32% -$119K ﹤0.01% 618
2020
Q2
$309K Sell
1,771
-199
-10% -$31.8K ﹤0.01% 552
2020
Q1
$249K Buy
+1,970
New +$295K ﹤0.01% 572
2019
Q3
Sell
-2,724
Closed -$387K 857
2019
Q2
$387K Sell
2,724
-144
-5% -$19.5K ﹤0.01% 667
2019
Q1
$417K Buy
+2,868
New +$377K ﹤0.01% 607
2018
Q1
Sell
-4,304
Closed -$471K 896
2017
Q4
$471K Hold
4,304
﹤0.01% 611
2017
Q3
$465K Sell
4,304
-1,046
-20% -$107K ﹤0.01% 641
2017
Q2
$541K Buy
5,350
+14
+0.3% +$1.29K ﹤0.01% 430
2017
Q1
$480K Buy
+5,336
New +$453K ﹤0.01% 517
2016
Q3
Sell
-5,597
Closed -$461K 686
2016
Q2
$461K Sell
5,597
-408
-7% -$33.6K ﹤0.01% 313
2016
Q1
$456K Sell
6,005
-1,040
-15% -$77K ﹤0.01% 317
2015
Q4
$566K Hold
7,045
0.01% 303
2015
Q3
$4.47K Buy
7,045
+597
+9% +$42.9K ﹤0.01% 588
2015
Q2
$454K Buy
6,448
+100
+2% +$7.4K ﹤0.01% 593
2015
Q1
$503K Sell
6,348
-2,298
-27% -$170K ﹤0.01% 571
2014
Q4
$550K Sell
8,646
-1,254
-13% -$78.6K ﹤0.01% 377
2014
Q3
$591K Buy
+9,900
New +$566K ﹤0.01% 316

Other funds holding CRL